Oncovision will have a bold presence at this year’s RSNA in Chicago. In our inviting booth we will proudly show customers cutting edge technology like W-Probe and Sentinella. The main focus, however, will be the Mammi dedicated breast PET, which has just obtained FDA approval, a huge milestone in Oncovision’s history. Mamma dbPET is raising MOLECULAR BREAST IMAGING to a new level, with extremely high sensitivity and specificity and short scan times.
We are proud to welcome Prof. Michel Herranz, who will be giving a presentation on real Mammi PET cases from his own experience every day at 2:00 pm in the Oncovision booth.